Fenglin Chen

Dr. Fenglin Chen


Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 February 2021 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
FDFan Du
Fan Du
RHRongfeng Huang
Rongfeng Huang
DLDan Lin
Dan Lin
YWYuying Wang
Yuying Wang
XYXiaohuang Yang
Xiaohuang Yang
FCFenglin Chen
Fenglin Chen
Resveratrol (RSV) is a potential alternative therapy for non-alcoholic fatty liver disease (NAFLD) that has been evaluated in many clinical trials, but the mechanisms of RSV action have not been fully elucidated. Recent studies suggested that the gut microbiota is an important RSV target; therefore, we speculated that the gut microbiota might mediate the beneficial effects of RSV in NAFLD. To verify this hypothesis, we established a high-fat diet (HFD)-induced NAFLD mouse model, which was subjected to RSV gavage to evaluate the therapeutic effects. We observed that RSV reduced liver steatosis and insulin resistance in NAFLD. RSV significantly changed the diversity and composition of the gut microbiota according to 16S rRNA sequencing. Gut microbiota gene function prediction showed that the enrichment of pathways related to lipid and glucose metabolism decreased after RSV treatment. Furthermore, correlation analysis indicated that the improvements in NAFLD metabolic indicators were closely related to the altered gut microbiota. We further fermented RSV with the gut microbiota in vitro to verify that RSV directly affected the gut microbiota. Our data suggested that the gut microbiota might be an important target through which RSV exerts its anti-NAFLD effect.

1 February 2023 in Journal of Digestive Diseases
Verified
Journal Article
Closed access
BJBin Jiang
Bin Jiang
JPJun Pan
Jun Pan
YQYang Yang Qian
Yang Yang Qian
CHChen He
Chen He
JXJi Xia
Ji Xia
TEthe Capsule Endoscopy Group of the Chinese Society of Digestive Endoscopy
the Capsule Endoscopy Group of the Chinese Society of Digestive Endoscopy

5 April 2022 in European Journal of Gastroenterology & Hepatology
Verified
Journal Article
Open access
QHQiYong He
QiYong He
JDJian Ding
Jian Ding
SHShanShan He
ShanShan He
YYYunWen Yu
YunWen Yu
XCXiaoPing Chen
XiaoPing Chen
FCFenglin Chen
Fenglin Chen
Objective: The objective of this study is to investigate the predictive value of a parametric model constructed by using procalcitonin, C-reactive protein (CRP) and D dimer within 48 h after admission in moderately severe and severe acute pancreatitis. Methods: A total of 238 patients were enrolled, of which 170 patients were moderately severe and severe acute pancreatitis (MSAP+SAP). The concentrations of procalcitonin, CRP and D dimer within 48 h after admission were obtained. The predictive value of the parametric model, modified computed tomography severity index (MCTSI), bedside index for severity in acute pancreatitis (BISAP), Ranson score, Acute Physiology and Chronic Health Evaluation II (APACHE II) score, modified Marshall score and systemic inflammatory response syndrome (SIRS) score of all patients was calculated and compared. Results: The area under receiver operator characteristic curve, sensitivity, specificity, Youden index and critical value of the parametric model for predicting MSAP+SAP were 0.853 (95% CI, 0.804–0.903), 84.71%, 70.59%, 55.30% and 0.2833, respectively. The sensitivity of the parametric model was higher than that of MCTSI (84.00%), Ranson score (73.53%), BISAP (56.47%), APACHE II score (27.65%), modified Marshall score (17.06%) and SIRS score (78.24%); the specificity of it were higher than that of MCTSI (52.94%) and Ranson score (67.65%), but lower than BISAP (73.53%), APACHE II score (76.47%), modified Marshall score (100%)and SIRS score (100.00%). Conclusion: The parametric model constructed by using procalcitonin 48 h, CRP 48 h and D dimer 48 h can be regarded as an evaluation model for predicting moderately severe and severe acute pancreatitis.

15 July 2020 in Journal of Gastroenterology and Hepatology
Verified
Journal Article
Closed access
PDF file
HLHao Lin
Hao Lin
JWJunyong Weng
Junyong Weng
HMHaitao Mei
Haitao Mei
MZMingkai Zhuang
Mingkai Zhuang
XXXinzhu Xiao
Xinzhu Xiao
XWXIAOZHONG WANG
XIAOZHONG WANG

20 May 2021 in Advances in Therapy
Verified
Journal Article
Closed access
PDF file
JWJinpo Wang
Jinpo Wang
RHRongfeng Huang
Rongfeng Huang
YHYuehong Huang
Yuehong Huang
YCYunxin Chen
Yunxin Chen
FCFenglin Chen
Fenglin Chen

10 December 2023 in International Immunopharmacology
Verified
Journal Article
Open access
YCYizhen Chen
Yizhen Chen
YHYixuan Huang
Yixuan Huang
RHRongfeng Huang
Rongfeng Huang
ZCZhixin Chen
Zhixin Chen
XWXiaozhong Wang
Xiaozhong Wang
YHYuehong Huang
Yuehong Huang
Interleukin 10 (IL-10) and natural killer (NK) cells have the potential to combat liver fibrosis. However, whether NK cells play an important role in the anti-fibrotic effects of IL-10 is not sufficiently elucidated. In this study, we investigated the regulatory effects of IL-10 on NK cells during liver fibrosis. Fibrotic mice induced with carbon tetrachloride were treated with or without IL-10 in the presence or absence of NK cells. Liver damage and fibrosis were assessed using hematoxylin and eosin and Sirius Red staining and serum transaminase and liver hydroxyproline assays, respectively. NK cell distribution, quantity, activation, cytotoxicity, development, and origin were analyzed using immunohistochemistry, immunofluorescence, and flow cytometry. Enzyme-linked immunosorbent assay was used to determine chemokine levels. In the presence of NK cells, IL-10 gene intervention improved liver fibrosis and enhanced NK cell accumulation and function in the liver, as evidenced by increased NKG2D, interferon-γ, and CD107a expression. Furthermore, IL-10 promoted the migration of circulating NK cells to the fibrotic liver and elevated C-C motif ligand 5 levels. However, depletion of NK cells exacerbated liver fibrosis and impaired the anti-fibrotic effect of IL-10. The anti-fibrotic effect of IL-10 relies on the enhancement of NK cell immune function, including activation, cytotoxicity, development, and migration. These results provide valuable insights into the mechanisms through which IL-10 regulates NK cells to limit the progression of liver fibrosis.